T-cell Therapy

T cells are immune cells that combat infection. In T-cellular therapy, the health practitioner gets rid of T cells from the blood. Then, a laboratory adds unique proteins called receptors to the cells. The receptor lets in those T cells to recognize cancer cells. The modified T cells are put back into the frame. Once there, they discover and wreck cancer cells. This sort of therapy is referred to as chimeric antigen receptor (CAR) T-cell therapy. Side outcomes encompass fevers, confusion, low blood pressure, and, in uncommon events, seizures. CAR T-cell therapy is used to deal with sure blood cancers. Researchers are still studying this kind of remedy and different approaches of converting T cells to deal with cancer.

    Related Conference of T-cell Therapy

    May 23-24, 2024

    18th International Conference on European Immunology

    Zurich, Switzerland
    October 24-25, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland

    T-cell Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in